In the latter study, the greatest number of activated ILC2, identified as IL-5/IL-13+ ILC2, was detected in sputum from severe asthma patients with uncontrolled airway eosinophilia (>3% sputum eosinophils) despite high-dose corticosteroid therapy. This evidence concerns the gene IL13 and asthma.